• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of February 22, 2023

    FDA

    IPC flags safety alert against dimethyl fumarate & cefazolin

    PHARMABIZ

    Enforcement Report - Week of October 6, 2021

    FDA

    IntegraDose Issues Voluntary Nationwide Recall of Cefazolin Injection

    FDA

    Enforcement Report - Week of May 1, 2019

    FDA

    Thrifty White Drug (Sterile and non-sterile drug producer) Receives FDA Form 483

    FDA

    HomeChoice Partners Receives FDA Form 483

    FDA

    Enforcement Report - Week of August 15, 2018

    FDA

    Enforcement Report - Week of July 25, 2018

    FDA

    Enforcement Report - Week of August 2, 2017

    FDA

    US FDA Enforcement Report- 8/June/2016

    FDA

    Celerity`s Cefazolin approved in US for bacterial infections

    FDA

    Baxter`s Cefazolin receives US FDA nod for preoperative prophylaxis treatment

    PHARMABIZ

    Drug shortages become issue in Teva and Mylan hook-up

    FIERCE PHARMA MANUFACTURING

    FDA Drug Shortages: Cefazolin Injection

    FDA

    Recall: Cefazoline for Injection

    HEALTHY CANADIANS

    Walgreens Infusion Services, Ongoing Class II recall of Cefazolin various strengths in normal saline bags because of Lack of sterility assurance.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.